First Time Loading...

Immutep Ltd
ASX:IMM

Watchlist Manager
Immutep Ltd Logo
Immutep Ltd
ASX:IMM
Watchlist
Price: 0.44 AUD Market Closed
Updated: May 30, 2024

Immutep Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immutep Ltd
Interest Income Expense Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Immutep Ltd
ASX:IMM
Interest Income Expense
AU$2.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
14%
Mesoblast Ltd
ASX:MSB
Interest Income Expense
-$18.4m
CAGR 3-Years
-7%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Interest Income Expense
-$469m
CAGR 3-Years
-38%
CAGR 5-Years
-27%
CAGR 10-Years
-25%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Interest Income Expense
-AU$3.5m
CAGR 3-Years
-17%
CAGR 5-Years
N/A
CAGR 10-Years
-40%
Telix Pharmaceuticals Ltd
ASX:TLX
Interest Income Expense
-AU$733k
CAGR 3-Years
60%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Interest Income Expense
-AU$422.3k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Immutep Ltd's Interest Income Expense?
Interest Income Expense
2.8m AUD

Based on the financial report for Dec 31, 2023, Immutep Ltd's Interest Income Expense amounts to 2.8m AUD.

What is Immutep Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
14%

Over the last year, the Interest Income Expense growth was 33%.